SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-20-005975
Filing Date
2020-06-25
Accepted
2020-06-25 20:19:01
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT fusn-form3_062520.html 3  
1 OWNERSHIP DOCUMENT fusn-form3_062520.xml 3 11165
  Complete submission text file 0001387131-20-005975.txt   13485
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990689

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
COULTER JAMES G (Reporting) CIK: 0001099776 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990690

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Reporting) CIK: 0001495741 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990688

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)